Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04679454 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Single Fraction Preoperative Radiotherapy for Early Stage Breast Cancer

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 5, 2024 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Phase: Phase 1/2 to Not applicablev4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 2021 to Jul 31, 2021
    • Study sites: 0 to 1
    v3
  3. Secondary endpoints revised (7)v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a phase I/II, single-arm and open-label single-centre clinical trial with the aim to test the feasibility, safety and the efficacy, in terms of complete pathological response, of preoperative ablative radiotherapy in single fraction for selected breast cancer patients.
Trial Details
NCT Number NCT04679454
Lead Sponsor European Institute of Oncology
Conditions
(from sponsor)		 Breast Cancer
Related terms Breast Neoplasms
Enrollment 79 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov